Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 977

1.

Rectal indometacin dose escalation for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography in high-risk patients: a double-blind, randomised controlled trial.

Fogel EL, Lehman GA, Tarnasky P, Cote GA, Schmidt SE, Waljee AK, Higgins PDR, Watkins JL, Sherman S, Kwon RSY, Elta GH, Easler JJ, Pleskow DK, Scheiman JM, El Hajj II, Guda NM, Gromski MA, McHenry L Jr, Arol S, Korsnes S, Suarez AL, Spitzer R, Miller M, Hofbauer M, Elmunzer BJ; US Cooperative for Outcomes Research in Endoscopy (USCORE).

Lancet Gastroenterol Hepatol. 2019 Nov 25. pii: S2468-1253(19)30337-1. doi: 10.1016/S2468-1253(19)30337-1. [Epub ahead of print]

PMID:
31780277
2.

Use of Accelerated Induction Strategy of Infliximab for Ulcerative Colitis in Hospitalized Patients at a Tertiary Care Center.

Govani SM, Berinstein JA, Waljee AK, Stidham RW, Higgins PDR, Hardiman KM.

Dig Dis Sci. 2019 Nov 20. doi: 10.1007/s10620-019-05957-0. [Epub ahead of print]

PMID:
31748921
3.

In vitro and in vivo Virulence Potential of the Emergent Species of the Acinetobacter baumannii (Ab) Group.

Cosgaya C, Ratia C, Marí-Almirall M, Rubio L, Higgins PG, Seifert H, Roca I, Vila J.

Front Microbiol. 2019 Oct 24;10:2429. doi: 10.3389/fmicb.2019.02429. eCollection 2019.

4.

In-vitro activity of the novel fluorocycline TP-6076 against carbapenem-resistant Acinetobacter baumannii.

Seifert H, Stefanik D, Olesky M, Higgins PG.

Int J Antimicrob Agents. 2019 Oct 26. pii: S0924-8579(19)30290-0. doi: 10.1016/j.ijantimicag.2019.10.010. [Epub ahead of print]

PMID:
31669740
5.

Genetic Features of Antarctic Acinetobacter radioresistens Strain A154 Harboring Multiple Antibiotic-Resistance Genes.

Opazo-Capurro A, Higgins PG, Wille J, Seifert H, Cigarroa C, González-Muñoz P, Quezada-Aguiluz M, Domínguez-Yévenes M, Bello-Toledo H, Vergara L, González-Rocha G.

Front Cell Infect Microbiol. 2019 Sep 13;9:328. doi: 10.3389/fcimb.2019.00328. eCollection 2019.

6.

Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis.

Sands BE, Sandborn WJ, Panaccione R, O'Brien CD, Zhang H, Johanns J, Adedokun OJ, Li K, Peyrin-Biroulet L, Van Assche G, Danese S, Targan S, Abreu MT, Hisamatsu T, Szapary P, Marano C; UNIFI Study Group.

N Engl J Med. 2019 Sep 26;381(13):1201-1214. doi: 10.1056/NEJMoa1900750.

PMID:
31553833
7.

Exenatide regulates pancreatic islet integrity and insulin sensitivity in the nonhuman primate baboon Papio hamadryas.

Fiorentino TV, Casiraghi F, Davalli AM, Finzi G, La Rosa S, Higgins PB, Abrahamian GA, Marando A, Sessa F, Perego C, Guardado-Mendoza R, Kamath S, Ricotti A, Fiorina P, Daniele G, Paez AM, Andreozzi F, Bastarracea RA, Comuzzie AG, Gastaldelli A, Chavez AO, Di Cairano ES, Frost P, Luzi L, Dick EJ, Halff GA, DeFronzo RA, Folli F.

JCI Insight. 2019 Oct 17;4(20). pii: 93091. doi: 10.1172/jci.insight.93091.

8.

Assessing Small Bowel Stricturing and Morphology in Crohn's Disease Using Semi-automated Image Analysis.

Stidham RW, Enchakalody B, Waljee AK, Higgins PDR, Wang SC, Su GL, Wasnik AP, Al-Hawary M.

Inflamm Bowel Dis. 2019 Aug 29. pii: izz196. doi: 10.1093/ibd/izz196. [Epub ahead of print]

PMID:
31504540
9.

The Association of Medications and Vaccination with Risk of Pneumonia in Inflammatory Bowel Disease.

Gregory MH, Ciorba MA, Wiitala WL, Stidham RW, Higgins P, Morley SC, Hou JK, Feagins LA, Govani SM, Cohen-Mekelburg SA, Waljee AK.

Inflamm Bowel Dis. 2019 Aug 27. pii: izz189. doi: 10.1093/ibd/izz189. [Epub ahead of print]

PMID:
31504531
10.

Strain-Photoacoustic Imaging as a Potential Tool for Characterizing Intestinal Fibrosis.

Zhu Y, Johnson LA, Rubin JM, Appelman H, Ni L, Yuan J, Wang X, Higgins PDR, Xu G.

Gastroenterology. 2019 Nov;157(5):1196-1198. doi: 10.1053/j.gastro.2019.07.061. Epub 2019 Aug 13. No abstract available.

PMID:
31419434
11.

Restoring the activity of the antibiotic aztreonam using the polyphenol epigallocatechin gallate (EGCG) against multidrug-resistant clinical isolates of Pseudomonas aeruginosa.

Betts JW, Hornsey M, Higgins PG, Lucassen K, Wille J, Salguero FJ, Seifert H, La Ragione RM.

J Med Microbiol. 2019 Oct;68(10):1552-1559. doi: 10.1099/jmm.0.001060.

PMID:
31419210
12.

The TGF-β1/p53/PAI-1 Signaling Axis in Vascular Senescence: Role of Caveolin-1.

Samarakoon R, Higgins SP, Higgins CE, Higgins PJ.

Biomolecules. 2019 Aug 3;9(8). pii: E341. doi: 10.3390/biom9080341. Review.

13.

Imaging Features Associated With Failure of Nonoperative Management of Intraabdominal Abscesses in Crohn Disease.

Perl D, Waljee AK, Bishu S, Higgins PDR, Wasnik AP, Stidham RW.

Inflamm Bowel Dis. 2019 Nov 14;25(12):1939-1944. doi: 10.1093/ibd/izz069.

PMID:
31294779
14.

TGF-β1-p53 cooperativity regulates a profibrotic genomic program in the kidney: molecular mechanisms and clinical implications.

Higgins CE, Tang J, Mian BM, Higgins SP, Gifford CC, Conti DJ, Meldrum KK, Samarakoon R, Higgins PJ.

FASEB J. 2019 Oct;33(10):10596-10606. doi: 10.1096/fj.201900943R. Epub 2019 Jul 6.

PMID:
31284746
15.

Challenges in the Pathophysiology, Diagnosis and Management of Intestinal Fibrosis in Inflammatory Bowel Disease.

D'Haens G, Rieder F, Feagan BG, Higgins PDR, Panes J, Maaser C, Rogler G, Löwenberg M, van der Voort R, Pinzani M, Peyrin-Biroulet L, Danese S; IOIBD Fibrosis Working Group.

Gastroenterology. 2019 Jun 26. pii: S0016-5085(19)41035-4. doi: 10.1053/j.gastro.2019.05.072. [Epub ahead of print]

PMID:
31254502
16.

Analysis of Genetic Association of Intestinal Permeability in Healthy First-degree Relatives of Patients with Crohn's Disease.

Turpin W, Espin-Garcia O, Bedrani L, Madsen K, Meddings JB, Raygoza Garay JA, Silverberg MS, Smith MI, Griffiths AM, Moayyedi P, Marshall JK, Mack D, Seidman EG, Ropeleski M, Feagan BG, Jacobson K, Turner D, Walters T, Paterson AD; CCC GEM Project Research Consortium , Xu W, Croitoru K.

Inflamm Bowel Dis. 2019 Oct 18;25(11):1796-1804. doi: 10.1093/ibd/izz116.

PMID:
31251335
17.

Controlling intestinal colonization of high-risk haematology patients with ESBL-producing Enterobacteriaceae: a randomized, placebo-controlled, multicentre, Phase II trial (CLEAR).

Dimitriou V, Biehl LM, Hamprecht A, Vogel W, Dörfel D, Peter S, Schafhausen P, Rohde H, von Lilienfeld-Toal M, Klassert TE, Slickers P, Ehricht R, Slevogt H, Christ H, Hellmich M, Farowski F, Tsakmaklis A, Higgins PG, Seifert H, Vehreschild MJGT.

J Antimicrob Chemother. 2019 Jul 1;74(7):2065-2074. doi: 10.1093/jac/dkz124.

PMID:
31220256
18.

The adequacy of lymph node clearance in colon cancer surgery performed in a non-specialist centre; implications for practice.

Higgins P, Nemeth T, Bennani F, Khan W, Khan I, Waldron R, Barry K.

Ir J Med Sci. 2019 Jun 19. doi: 10.1007/s11845-019-02044-1. [Epub ahead of print]

PMID:
31218518
19.

Generation and selection of antibodies for a novel immunochromatographic lateral flow test to rapidly identify OXA-23-like-mediated carbapenem resistance in Acinetobacter baumannii.

Mertins S, Higgins PG, Rodríguez MG, Borlon C, Gilleman Q, Mertens P, Seifert H, Krönke M, Klimka A.

J Med Microbiol. 2019 Jul;68(7):1021-1032. doi: 10.1099/jmm.0.001015. Epub 2019 Jun 12.

PMID:
31188094
20.

In vitro activity of mecillinam and nitroxoline against Neisseria gonorrhoeae - re-purposing old antibiotics in the multi-drug resistance era.

Fuchs F, Wille J, Hamprecht A, Parcina M, Lehmann C, Schwarze-Zander C, Seifert H, Higgins PG.

J Med Microbiol. 2019 Jul;68(7):991-995. doi: 10.1099/jmm.0.001014. Epub 2019 Jun 4.

PMID:
31162022

Supplemental Content

Loading ...
Support Center